These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3281031)

  • 21. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
    Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
    J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
    Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
    Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M
    Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
    Walker MD; Green SB; Byar DP; Alexander E; Batzdorf U; Brooks WH; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Owens G; Ransohoff J; Robertson JT; Shapiro WR; Smith KR; Wilson CB; Strike TA
    N Engl J Med; 1980 Dec; 303(23):1323-9. PubMed ID: 7001230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival?
    Laramore GE; Martz KL; Nelson JS; Griffin TW; Chang CH; Horton J
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1351-6. PubMed ID: 2689399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiotherapy of malignant glioma--prospective randomized clinical study of whole brain vs local irradiation].
    Kita M; Okawa T; Tanaka M; Ikeda M
    Gan No Rinsho; 1989 Sep; 35(11):1289-94. PubMed ID: 2681872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN; Zhang P; Yung WKA; Chen Y; Movsas B; Urtasun RC; Jones CU; Choi KN; Michalski JM; Fischbach AJ; Markoe AM; Schultz CJ; Penas-Prado M; Garg MK; Hartford AC; Kim HE; Won M; Curran WJ
    J Neurooncol; 2018 Mar; 137(1):39-47. PubMed ID: 29404979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemical modifiers in radiotherapy].
    Nagashima T; Takakura K
    Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Accelerated hyperfractionation in the treatment of malignant glioma].
    Sugawara T; Nakazawa M; Mizutani Y; Hyodoh H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):278-85. PubMed ID: 8177703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
    Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
    Curran WJ; Scott CB; Nelson JS; Weinstein AS; Phillips TL; Murray K; Fischbach AJ; Yakar D; Schwade JG; Powlis WD
    Cancer; 1992 Dec; 70(12):2909-17. PubMed ID: 1451073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
    Walker MD; Alexander E; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Norrell HA; Owens G; Ransohoff J; Wilson CB; Gehan EA; Strike TA
    J Neurosurg; 1978 Sep; 49(3):333-43. PubMed ID: 355604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.
    Shapiro WR; Green SB; Burger PC; Mahaley MS; Selker RG; VanGilder JC; Robertson JT; Ransohoff J; Mealey J; Strike TA
    J Neurosurg; 1989 Jul; 71(1):1-9. PubMed ID: 2661738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival in treated anaplastic astrocytomas. A report of combined RTOG/ECOG studies.
    Fischbach AJ; Martz KL; Nelson JS; Griffin TW; Chang CH; Horton J; Nelson DF
    Am J Clin Oncol; 1991 Oct; 14(5):365-70. PubMed ID: 1659173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy.
    Sweet DL; Hendler FJ; Hanlon K; Hekmatpanah J; Griem ML; Duda EE; Mulligan B; Wollman RL
    Cancer Treat Rep; 1979; 63(11-12):1707-11. PubMed ID: 230893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon as adjuvant therapy with initial radiotherapy of patients with anaplastic gliomas.
    Mahaley MS; Urso MB; Whaley RA; Williams TE; Guaspari A
    J Neurosurg; 1984 Dec; 61(6):1069-71. PubMed ID: 6209367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.